Portfolio company
Genomate
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Genomate Health develops AI software that analyses genomic data to help oncologists and patients identify personalized cancer treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
4baseCare
This company develops genomic tests and AI-powered clinical decision support tools for oncologists, hospitals, and pharmaceutical researchers to personalise cancer treatment.
Genetico
Genetico develops AI-enabled software for clinical genetic data management and decision support, serving hospitals, laboratories and public health programmes managing rare diseases.
Astron Health
This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.
Genomill Health
Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.
Oncompass
Oncompass develops oncology software that identifies genetic mutations to help clinicians select personalised cancer treatment options for patients.
Imagenomix
The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.
DoMore Diagnostics
This company develops artificial intelligence software for digital pathology to help oncologists and pathologists provide personalised cancer treatment paths for patients.
Genorare
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
